15159478

Source:http://linkedlifedata.com/resource/pubmed/id/15159478

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0028945, umls-concept:C0443252, umls-concept:C1274040
pubmed:issue	10
pubmed:dateCreated	2004-5-25
pubmed:abstractText	Favorable prognostic factors for oligodendroglial tumors include age younger than 40 years, low tumor grade, and extent of resection.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0401060
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Dacarbazine, http://linkedlifedata.com/resource/pubmed/chemical/Etoposide, http://linkedlifedata.com/resource/pubmed/chemical/Lomustine, http://linkedlifedata.com/resource/pubmed/chemical/Nitrosourea Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Organophosphorus Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Procarbazine, http://linkedlifedata.com/resource/pubmed/chemical/Radiopharmaceuticals, http://linkedlifedata.com/resource/pubmed/chemical/Technetium Tc 99m Sestamibi, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine, http://linkedlifedata.com/resource/pubmed/chemical/fotemustine, http://linkedlifedata.com/resource/pubmed/chemical/temozolomide
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1526-632X
pubmed:author	pubmed-author:BourgVV, pubmed-author:ChanaletSS, pubmed-author:ChatelMM, pubmed-author:FontaineDD, pubmed-author:FrenayMM, pubmed-author:LebrunCC, pubmed-author:LonjonMM, pubmed-author:MichielsJ FJF, pubmed-author:Nice Brain Tumor Study Group, pubmed-author:PaquisPP, pubmed-author:RamaioliAA, pubmed-author:VandenbosFF
pubmed:issnType	Electronic
pubmed:day	25
pubmed:volume	62
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1783-7
pubmed:dateRevised	2006-4-24
pubmed:meshHeading	pubmed-meshheading:15159478-Adolescent, pubmed-meshheading:15159478-Adult, pubmed-meshheading:15159478-Aged, pubmed-meshheading:15159478-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15159478-Biopsy, pubmed-meshheading:15159478-Brain Neoplasms, pubmed-meshheading:15159478-Cisplatin, pubmed-meshheading:15159478-Combined Modality Therapy, pubmed-meshheading:15159478-Cranial Irradiation, pubmed-meshheading:15159478-Craniotomy, pubmed-meshheading:15159478-Dacarbazine, pubmed-meshheading:15159478-Epilepsies, Partial, pubmed-meshheading:15159478-Etoposide, pubmed-meshheading:15159478-Female, pubmed-meshheading:15159478-Follow-Up Studies, pubmed-meshheading:15159478-Humans, pubmed-meshheading:15159478-Life Tables, pubmed-meshheading:15159478-Lomustine, pubmed-meshheading:15159478-Magnetic Resonance Imaging, pubmed-meshheading:15159478-Male, pubmed-meshheading:15159478-Middle Aged, pubmed-meshheading:15159478-Neoadjuvant Therapy, pubmed-meshheading:15159478-Nitrosourea Compounds, pubmed-meshheading:15159478-Oligodendroglioma, pubmed-meshheading:15159478-Organophosphorus Compounds, pubmed-meshheading:15159478-Procarbazine, pubmed-meshheading:15159478-Prognosis, pubmed-meshheading:15159478-Proportional Hazards Models, pubmed-meshheading:15159478-Radiopharmaceuticals, pubmed-meshheading:15159478-Survival Analysis, pubmed-meshheading:15159478-Technetium Tc 99m Sestamibi, pubmed-meshheading:15159478-Treatment Outcome, pubmed-meshheading:15159478-Vincristine
pubmed:year	2004
pubmed:articleTitle	Long-term outcome of oligodendrogliomas.
pubmed:affiliation	Department of Neurology, Hôpital Pasteur, Nice, France. christine.lebrun-frenay@wanadoo.fr
pubmed:publicationType	Journal Article